Advertisement
Fighting liver cancer, quality of life
Cleveland Clinic’s Liver Tumor Clinic is designed to provide leading-edge management and treatment of diverse and complex liver malignancies. Patients have access to a multidisciplinary team of specialists — hepatobiliary and transplant surgeons, hepatologists, oncologists, radiation oncologists, interventional radiologists and specialized nurse coordinators — in a one-stop clinic, eliminating multiple appointments with different physicians at various locations.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Federico Aucejo, MD, heads the Liver Tumor Clinic, and says the innovative multidisciplinary model allows the elaboration of treatment strategies tailored to each individual patient. The model — based on comprehensive disease evaluations, liver malignancy care paths and Tumor Board consensus — allows delivery of cost/effective individualized therapies. Patients are evaluated and treatment is coordinated in a short timeframe: less than 30 days.
“Physicians review medical records, image studies and laboratory values of all patients who are evaluated through the clinic in one central location. The presence of diverse specialists allows interdisciplinary discussions maximizing the patients’ options,” Dr. Aucejo says. “The concept of articulating value-based multidisciplinary clinics, care paths and tumor boards is evolving, innovative and adapts to the changing physiognomy of healthcare.”
The number of patients diagnosed with liver cancer continues to rise due to a variety of reasons including inefficient cancer screening and surveillance programs and emerging uncontrolled risk factors, Dr. Aucejo says.
The Liver Tumor Clinic treats all types of liver cancers including:
Treatment options include diverse surgical interventions, and locoregional and medical oncological therapies only offered by the most highly specialized centers in the nation:
Advertisement
Such a multidisciplinary approach is invaluable to patients with liver cancers, says Cleveland Clinic oncologist Bassam Estfan, MD.
“Having such a resource at our disposal is an extremely valuable tool for optimal care for the increasingly complex and challenging cases we see,” Dr. Estfan says. “Shared clinic visits allow the team to discuss care as viewed from different vantage points. The cumulative multispecialty expertise allows piecing together different aspects of treatment and management to form a comprehensive care plan that is unique to every patient.”
Innovation and treatment discoveries are pivotal within the mission of Cleveland Clinic’s Liver Tumor Clinic. Some of these endeavors include:
For questions, contact Dr. Aucejo at aucejof@ccf.org. Refer a patient by calling 855.REFER.123.
Advertisement
Advertisement
Prediction and bioinformatic data could prove valuable for therapeutic interventions targeting this malignancy
Study measures real-world outcomes for relapsed or refractory large B-cell lymphoma
Optimized responses in transplant- and CAR T-cell therapy-eligible patients
Phase 3 trial found no survival differences between weekly or biweekly doxorubicin/cyclophosphamide or between weekly or biweekly paclitaxel
Findings strengthen evidence for risk-reducing procedures
Findings from large database important to inform clinical practice
Socioeconomic disparities have a notable influence on access to allogeneic hematopoietic cell transplant
Offers a new option for patients 60 and older with relapsed/refractory disease